Achromobacter xylosoxidans: a drug-resistant pathogen in newborns and immunocompromised patients.
Giacoia
G P
GP
Department of Pediatrics, University of Oklahoma College of Medicine, Tulsa.
D001018:Aortic Diseases / Q000601:surgery; D001424:Bacterial Infections / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D002437:Cefazolin / Q000627:therapeutic use*; D005260:Female; D006088:Gram-Negative Aerobic Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D007108:Immune Tolerance; D007231:Infant, Newborn; D008826:Microbial Sensitivity Tests; D011183:Postoperative Complications / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D011292:Premedication
D002437:Cefazolin